國立高雄大學圖資館 |

Language: English

Back

Biomarkers in liver disease

Patel, Vinood B.

Biomarkers in liver disease

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biomarkers in liver diseaseedited by Vinood B. Patel, Victor R. Preedy.
other author:	Patel, Vinood B.
Published:	Dordrecht :Springer Netherlands :2017.
Description:	xxvii, 1013 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	LiverDiseases
Online resource:	http://dx.doi.org/10.1007/978-94-007-7675-3
ISBN:	9789400776753$q(electronic bk.)

Biomarkers in liver disease
Biomarkers in liver disease[electronic resource] /edited by Vinood B. Patel, Victor R. Preedy. - Dordrecht :Springer Netherlands :2017. - xxvii, 1013 p. :ill., digital ;24 cm. - Biomarkers in disease: methods, discoveries and applications,2542-3657. - Biomarkers in disease: methods, discoveries and applications..

Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease -- Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers -- Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma -- Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease.

There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types. As the consequences of liver failure can be devastating it is important that appropriate diagnosis and monitoring is carried out. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.

ISBN: 9789400776753$q(electronic bk.)

Standard No.: 10.1007/978-94-007-7675-3doiSubjects--Topical Terms:

785073
Liver
--Diseases

LC Class. No.: RC847

Dewey Class. No.: 616.362075

Biomarkers in liver disease
LDR:04105nmm a2200325 a 4500 001 514866
003 DE-He213
005 20170531155808.0
006 m d
007 cr nn 008maaau
008 180126s2017 ne s 0 eng d
020 $a 9789400776753$q(electronic bk.)
020 $a 9789400776746$q(paper)
024 7 $a 10.1007/978-94-007-7675-3 $2 doi
035 $a 978-94-007-7675-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC847
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.362075 $2 23
090 $a RC847 $b .B615 2017
245 0 0 $a Biomarkers in liver disease $h [electronic resource] / $c edited by Vinood B. Patel, Victor R. Preedy.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2017.
300 $a xxvii, 1013 p. : $b ill., digital ; $c 24 cm.
490 1 $a Biomarkers in disease: methods, discoveries and applications, $x 2542-3657
505 0 $a Liver biomarkers and their applications to nutritional interventions in animal studies -- AST-to-platelet ratio index (APRI) as marker in liver disease -- Inflammatory biomarkers in ascites -- Biomarkers for hepatocellular carcinoma in East Asia -- Liver disease and acylcarnitines as mechanistic biomarkers -- Type VI Collagen: Biological Functions and its Neo-epitope as Hepatic Fibrosis Biomarker -- Fibrinogen α-chain as a serum marker of liver disease -- Monocyte chemotactic protein-1 (cytokine, receptors,and gene polymorphisms) in hepatitis -- Biomarkers for Recurrence of Hepatocellular Carcinoma -- Graft-derived cell-free DNA as a biomarker in liver transplantation -- Serum sialic acid as a biomarker in liver disease -- CD133 and EpCAM as Biomarkers in Liver Diseases -- Traditional markers in liver disease -- Biomarkers of extracellular matrix remodeling in liver diseases -- Squamous Cell Carcinoma Antigen- Immunoglobulin M (SCCA-IgM) as biomarker in liver disease: biological aspects and clinical applications -- microRNA-155 and microRNA-196b in hepatitis C virus infection -- Immunological biomarkers in liver transplantation -- Phosphatidylethanol and alcohol use in liver disease patients -- Interaction of sialyltransferases, sialidases and sialic acids in liver diseases and applications to biomarker discovery -- Biomarkers to monitor graft function following liver transplantation -- YKL-40 as a biomarker of liver diseases -- Peripheral venous, portal venous, hepatic venous, arterial and intrahepatic cytokine levels as biomarkers and functional correlations -- Histological Biomarkers of Non-Alcoholic Fatty Liver Disease -- Vascular cell adhesion molecule-1 (vcam-1) expression in liver disease -- Bilirubin as a biomarker in liver disease -- Hydroxyproline as a biomarker in liver disease -- Genetic biomarkers of paracetamol-induced acute liver failure -- PNPLA3 polymorphism and Nonalcoholic Fatty Liver Disease -- Hepascore and it's application to liver disease -- Model for End-Stage Liver Disease (MELD) Score as a Biomarker -- Biomarkers in focus: Alanine Aminotransferase -- PTX3 as a biomarker of liver disease.
520 $a There are numerous types of liver disease that may be due to toxic agents (such as alcohol or drugs), infectious agents including viruses, congenital conditions and even poor dietary patterns. It has been suggested that there are over 100 different types. As the consequences of liver failure can be devastating it is important that appropriate diagnosis and monitoring is carried out. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Liver Disease embraces a holistic approach by combining detailed information on different conditions that affect the liver and the use of biomarkers. Biomarkers are described in terms of conventional, new and emerging analytes, techniques, platforms and applications. It covers the latest knowledge, trends and innovations. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.
650 0 $a Liver $x Diseases $x Molecular diagnosis. $3 785073
650 0 $a Biochemical markers. $3 195446
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Oncology. $3 195181
650 2 4 $a Pharmacology/Toxicology. $3 273652
700 1 $a Patel, Vinood B. $3 586579
700 1 $a Preedy, Victor R. $3 301592
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Biomarkers in disease: methods, discoveries and applications. $3 759777
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-7675-3
950 $a Biomedical and Life Sciences (Springer-11642)